Faculty

	Kendall E. Donaldson, MD, MS (Co-Chair) Professor of Clinical Ophthalmology Medical Director Bascom Palmer Eye Institute in Plantation Plantation, Florida
	Walter O. Whitley, OD, MBA, FAAO (Co-Chair) Director, Optometric Services Virginia Eye Consultants Virginia Beach, Virginia

CME Reviewer for New York Eye and Ear Infirmary of Mount Sinai

Priti Batta, MD
Clinical Assistant Professor
Icahn School of Medicine at Mount Sinai
New York, New York

Disclosure Policy

It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

Disclosures

Kendall E. Donaldson, MD, MS, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Bausch & Lomb Incorporated; Dompé US, Inc; Eyevance; Johnson & Johnson Vision Care, Inc; Kala Pharmaceuticals; Lumenis; Omeros Corporation; TissueTech, Inc; and Zeiss.

Walter O. Whitley, OD, MBA, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Alcon; Allergan; Bausch & Lomb Incorporated; Bio-Tissue; Bruder Healthcare; Eyevance; Glaukos Corporation; Horizon Therapeutics plc; Johnson & Johnson Vision Care, Inc; Kala Pharmaceuticals; Notal Vision; Novartis Pharmaceuticals Corporation; Ocular Therapeutix, Inc; OCuSOFT Inc; Oyster Point Pharma, Inc; Quidel Corporation; Regener-Eyes; RVL Pharmaceuticals, Inc; ScienceBased Health; Sun Pharmaceutical Industries, Inc; Tarsus Pharmaceuticals, Inc; TearLab Corporation; and Thea Pharmaceuticals Limited; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Aerie Pharmaceuticals, Inc; Alcon; Bausch & Lomb Incorporated; Bio-Tissue; Eyevance; Novartis Pharmaceuticals Corporation; ScienceBased Health; and Sun Pharmaceutical Industries, Inc; and Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Leo Lens Technology, Inc.

New York Eye and Ear Infirmary of Mount Sinai Peer Review Disclosure

Priti Batta, MD, has no relevant commercial relationships to disclose.

Editorial Support Disclosures

Melissa Carter, MS; Cynthia Tornallyay, RD, MBA, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

Disclosure Attestation

The contributing physicians listed above have attested to the following:

1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
3. that all reasonable clinical alternatives will be discussed when making practice recommendations.